Elevance Health Files 8-K for Regulation FD Disclosure
Ticker: ELV · Form: 8-K · Filed: May 28, 2025 · CIK: 1156039
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: ELV
TL;DR
ELEVANCE HEALTH (ELV) FILED AN 8-K FOR REG FD DISCLOSURE - NO NEW INFO YET
AI Summary
Elevance Health, Inc. filed an 8-K on May 28, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or new material events beyond the disclosure itself.
Why It Matters
This filing indicates Elevance Health is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain any new material information that would immediately impact the company's risk profile.
Key Players & Entities
- Elevance Health, Inc. (company) — Registrant
- Regulation FD (regulation) — Disclosure type
- May 28, 2025 (date) — Filing date
- Anthem, Inc. (company) — Former company name
- WELLPOINT, INC (company) — Former company name
FAQ
What is the purpose of this 8-K filing by Elevance Health, Inc.?
The 8-K filing is for a Regulation FD Disclosure, meaning the company is making a public announcement to ensure all investors receive material information simultaneously.
When was this 8-K filed by Elevance Health, Inc.?
This 8-K was filed on May 28, 2025.
Does this filing contain specific financial results or new material events?
Based on the provided text, this filing is specifically for a Regulation FD Disclosure and does not detail specific financial results or new material events.
What is the principal executive office address for Elevance Health, Inc.?
The principal executive offices are located at 220 Virginia Ave, Indianapolis, IN 46204.
What are some of the former names of Elevance Health, Inc. mentioned in the filing?
The filing mentions former names including Anthem, Inc., WELLPOINT, INC, and WELLPOINT, INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Elevance Health, Inc. (ELV).